|
For
immediate release
|
23 July
2024
|
ALLIANCE
PHARMA
("Alliance", "Company" or the
"Group")
Senior Management and Board Update
Alliance Pharma plc (AIM: APH), the
international healthcare group, announces that Jeyan Heper, Chief
Operating Officer ("COO"), will leave the business on 31 August
2024.
Jeyan Heper joined Alliance as COO
and Board member on 1 February 2023, helping to identify growth
opportunities in international consumer healthcare markets and
supporting the Board and senior executive team to develop the
strategy for international markets, particularly China and the
US.
In order to accelerate the
globalisation of the business, to bring the consumer closer to the
heart of the business and to simplify the Company's management
structure, the Board has decided that the role of COO is no longer
a requirement at Alliance.
Nick
Sedgwick, Chief Executive Officer of Alliance,
said:
"I want to thank Jeyan for
his contribution to Alliance, providing stability
and valuable international consumer healthcare insights as we
continue on our journey to transform to a high performing consumer
healthcare company, built on a portfolio of leading, trusted and
proven brands. We wish him well in his future
endeavours."
For
further information:
|
Alliance Pharma plc
|
+ 44 (0)1249
466966
|
|
Cora McCallum, Head of Investor
Relations & Corporate Communications
|
+ 44
(0)1249 705168
|
|
ir@allianceph.com
|
|
|
|
|
|
Buchanan
|
+ 44 (0)20 7466
5000
|
|
Mark Court / Sophie Wills
|
|
|
alliancepharma@buchanan.uk.com
|
|
|
|
|
|
Deutsche Numis (Nominated Adviser and Joint
Broker)
|
+ 44 (0)20 7260
1000
|
|
Freddie Barnfield / Duncan Monteith
/ Sher Shah
|
|
|
|
|
|
Investec Bank plc (Joint Broker)
|
+ 44 (0)20 7597
5970
|
|
Patrick Robb / Maria Gomez de
Olea
|
|
About Alliance
Alliance Pharma plc (AIM: APH) is an
international healthcare group. Our purpose is to improve the lives
of consumers and patients through making available a range of
clinically valuable healthcare products.
Our core focus is on the marketing
of Consumer Healthcare brands, complemented by a smaller
Prescription Medicines business. In total, we hold marketing rights
to around 80 brands, with revenues generated from a mix of direct,
distributor and e-commerce sales.
Headquartered in the UK, the Group
employs around 290 people based in locations across Europe, North
America, and the Asia Pacific region. By outsourcing our
manufacturing and logistics operations, we remain asset-light and
focused on maximising the value of our brands.
For more information on Alliance,
please visit our website: www.alliancepharmaceuticals.com
